(Press-News.org) Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key gene that determines resistance to a range of cancer drugs has been reported in a study published by Cell Press November 21st in the journal Cell. The study reveals a biomarker that can predict responses to cancer drugs and offers a strategy to treat drug-resistant tumors based on their genetic signature.
"We need to understand the mechanisms of drug resistance to effectively prevent it from occurring in the first place," says senior study author René Bernards of the Netherlands Cancer Institute. "We have identified a mechanism of drug resistance that is caused by the activation of a specific signaling pathway in cancer cells."
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and NSCLC patients with a specific type of tumor mutation can be treated with a targeted therapy called crizotinib. But these patients frequently develop drug resistance as a result of secondary mutations in their tumors, through unknown genetic mechanisms.
To gain insight into this question, Bernards and his team developed a screen to identify genes whose suppression confers resistance to crizotinib in NSCLC cells. They discovered that inhibition of MED12, a gene that is mutated in cancers, resulted in resistance to not only crizotinib, but also other targeted drugs and chemotherapy used to treat various types of cancer.
The researchers also found that MED12 suppression caused drug resistance by enhancing signaling through the transforming growth factor beta receptor (TGF-betaR)—a protein involved in cell growth and cell death. By inhibiting TGF-betaR signaling in MED12-deficient cells, they were able to restore drug responsiveness. The results suggest that TGF-betaR inhibitors, which are currently being tested in clinical trials, may counter drug resistance in cancer patients with MED12 mutations.
"We have shown that blocking this escape route restores sensitivity to the original drug, suggesting a way to treat patients that have undergone this type of drug resistance." Bernards says.
###
Huang et al.: "MED12 controls the response to multiple cancer drugs through regulation of TGFbeta receptor signaling"
Drug resistance biomarker could improve cancer treatment
2012-11-21
ELSE PRESS RELEASES FROM THIS DATE:
Biomarking time
2012-11-21
Women live longer than men. Individuals can appear or feel years younger – or older – than their chronological age. Diseases can affect our aging process. When it comes to biology, our clocks clearly tick differently.
In a new study, researchers at the University of California, San Diego School of Medicine, with colleagues elsewhere, describe markers and a model that quantify how aging occurs at the level of genes and molecules, providing not just a more precise way to determine how old someone is, but also perhaps anticipate or treat ailments and diseases that come ...
Brain waves encode rules for behavior
2012-11-21
CAMBRIDGE, MA -- One of the biggest puzzles in neuroscience is how our brains encode thoughts, such as perceptions and memories, at the cellular level. Some evidence suggests that ensembles of neurons represent each unique piece of information, but no one knows just what these ensembles look like, or how they form.
A new study from researchers at MIT and Boston University (BU) sheds light on how neural ensembles form thoughts and support the flexibility to change one's mind. The research team, led by Earl Miller, the Picower Professor of Neuroscience at MIT, identified ...
A*STAR scientists identify potential drug target for inflammatory diseases including cancers
2012-11-21
A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause for the development of many human cancers, autoimmune disorders, neurodegenerative diseases, and metabolic diseases such as diabetes. This enzyme, which is known to be responsible for providing cancer cells the endless ability to divide, is now found to also jumpstart and maintain chronic inflammation in cancers.
In identifying this enzyme, inflammation can be prevented or reduced, and the common ...
Feature package of Congo Basin forest photos, stories & videos
2012-11-21
Stretching across central Africa, the Congo Basin forest is the second largest tract of rainforest in the world and a lifeline for more than 60 million people – providing food and income for many remote communities, storing huge amounts of carbon, supporting unique ecosystems and regulating the flow of the major rivers across Central Africa. Yet the Congo's forests are being cleared at an alarming rate amid global demand for the continent's minerals, energy and wood resources. Current methods and rates of extracting these resources are unsustainable and threatening the ...
Kidney tumors have a mind of their own
2012-11-21
TORONTO, Nov. 21, 2012-- New research has found there are several different ways that kidney tumours can achieve the same result – namely, grow.
Scientists have been trying to figure out how different people have kidney tumours with the same histology, or shape, although the genetic changes can vary among individual tumours.
Solving that puzzle could have implications for the diagnosis and treatment if kidney cancer, which has 35 per cent mortality rate and is becoming more common. Despite advances in early detection and treatment, the mortality rate hasn't changed in ...
The most popular TV series among youngsters in Spain recreates violence
2012-11-21
Published in the Comunicación journal, a study conducted by the University of Seville analyses violence content in Spanish TV series. It concludes that Telecinco's Sin tetas no hay paraíso is the most violent of the five studied.
Despite the fact that other series have more scenes or minutes of violence, according to the study, the Telecinco series is more powerful in its transmission of values that are more detrimental to youngsters in terms of their perception of aggressive behaviour and its consequences.
Sara González, the author of the study, explains to SINC ...
Flower power to purge poison and produce platinum
2012-11-21
A consortium of researchers led by WMG at the University of Warwick are to embark on a £3 million research programme called "Cleaning Land for Wealth" (CL4W), that will use a common class of flower to restore poisoned soils while at the same time producing perfectly sized and shaped nano sized platinum and arsenic nanoparticles for use in catalytic convertors, cancer treatments and a range of other applications.
A "Sandpit" exercise organised by the Engineering and Physical Sciences Research Council (EPSRC) allowed researchers from WMG (Warwick Manufacturing group) at ...
Researchers detail the migrations of the wood wasp Sirex noctilio
2012-11-21
In order to find out about its migrations, various research centres in South Africa, Sweden, Canada, Chile, Australia, Spain, Argentina and Switzerland have conducted research detailing its routes and expansion periods. A significant new fact has emerged and it is that the wasps returning to Europe from Chile and South Africa have undergone a genetic micro-evolution which makes them more resistant to their natural European enemy, a nematode that sterilises them.
The Sirex noctilio wasp is regarded as a secondary pest in Europe because in this geographical area there is ...
VTT: Indicators and methods of sustainable development 1-sided
2012-11-21
"Methods are required that take the social and environmental impacts of business operations better into account, both within the company and among its network of partners and stakeholders," says Uusitalo. "If a change cannot be effected, the current unsustainable way of life will continue, and we might also miss some opportunities for creating new business. Market share is at stake here."
According to Uusitalo, other companies and customers demand that companies take a wider view of sustainable development.
"Legislation will also inevitably lead development in this ...
Herbivore defense in ferns
2012-11-21
This press release is available in German.
They dominated the earth for 200 million years and numerous different species can still be found all over the world: mosses, horsetails and ferns. Researchers from the Max Planck Institute for Chemical Ecology in Jena, Germany, have now found out that bracken ferns (Pteridium aquilinum) do not release any volatiles when they are attacked − unlike many of the now dominant and evolutionary younger flowering plants. Such an emission of volatile compounds may attract the pest insects' enemies, such as ichneumon wasps or ...